Amazon Pharmacy starts offering Novo Nordisk’s Wegovy weight-loss pill

Amazon Expands Healthcare Reach with Novo Nordisk’s Wegovy Weight-Loss Pill

Amazon has announced that it will now offer Novo Nordisk’s Wegovy weight-loss pill through its digital pharmacy, marking a significant expansion of its healthcare services. The pill, which is an oral version of Novo Nordisk’s injectable obesity drug, will be available to eligible customers with insurance for as low as $25 per month, while cash-paying patients will be charged $149 per month.

The introduction of Wegovy to Amazon’s pharmacy comes as the company continues to push into the multitrillion-dollar U.S. healthcare industry. Amazon launched its pharmacy service in 2020, following the acquisition of online pharmacy PillPack in 2018, and has since sought to attract users with speedy delivery and price transparency. The company offers same-day prescription delivery to nearly half of U.S. consumers and has estimated annual revenue of around $2 billion.

Expanding Access to Obesity Treatment

The availability of Wegovy on Amazon underscores Novo Nordisk’s strategy to expand beyond traditional channels and reach new patients. The oral pill is also available at over 70,000 U.S. pharmacies, including CVS and Costco, as well as select telehealth providers. Health experts believe that oral options like Wegovy could expand access to obesity treatment in the U.S., reaching new people who may have been deterred by injectable treatments.

Novo Nordisk’s move into the oral obesity treatment market is seen as a significant development, with the company offering a starting dose of the pill for $149 per month to cash-paying patients. Patients with insurance coverage can access the pill for as low as $25 per month. The company has also partnered with other providers, including WeightWatchers, to deliver weight-loss medications to its members.

Competition in the Obesity Treatment Market

Eli Lilly, a rival pharmaceutical company, is also developing an obesity pill that is expected to win FDA approval later this year. The market for obesity treatments is highly competitive, with several companies vying for market share. Amazon’s partnership with Novo Nordisk to offer Wegovy is seen as a strategic move to expand its presence in the healthcare industry and provide more options to its customers.

As the healthcare industry continues to evolve, companies like Amazon and Novo Nordisk are playing a significant role in shaping the future of healthcare delivery. With the rise of digital pharmacies and telehealth services, patients have more options than ever before to access the treatments they need. The introduction of Wegovy to Amazon’s pharmacy is just one example of how companies are working together to expand access to healthcare services and improve patient outcomes.